Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14674390 | 0.90 | MAPT (0.51) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL537245 | 0.90 | LMNA (0.49) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL409033 | 0.88 | MAPT (0.52) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL27865301 | 0.87 | EGLN1 (0.45) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL28029409 | 0.87 | TSHR (0.51) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL14674409 | 0.86 | TSHR (0.48) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL27216258 | 0.86 | MAPT (0.55) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL5487490 | 0.86 | MAPT (0.55) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL605904 | 0.86 | MAPT (0.70) | MAPTTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL29054062 | 0.86 | TSHR (0.58) | MAPTTSHRLMNAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029798-B2 | Pre-targeting strategies for molecular imaging and/or radioimmunotherapy | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-07-09 | — | — | US | disclosed |
| US-11931423-B2 | Glucose oxidase-nanoparticle bioconjugates for cancer treatment | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-03-19 | — | — | US | disclosed |
| US-11857648-B2 | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023052127-A1 | PVC MIXTURE | LEONI KABEL GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| EP-2997076-B1 | SUPRAMOLECULAR BIODEGRADABLE POLYMER | SUPRAPOLIX BV (NL) | 2022-03-16 | — | — | EP | disclosed |
| US-20200085966-A1 | GLUCOSE OXIDASE-NANOPARTICLE BIOCONJUGATES FOR CANCER TREATMENT AND USES THEREOF | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-03-19 | — | — | US | disclosed |
| US-20190134240-A1 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-05-09 | — | — | US | disclosed |
| US-20190134239-A1 | PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-05-09 | — | — | US | disclosed |
| EP-2705879-B1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | HENKEL AG & CO KGAA (DE) | 2017-06-07 | — | — | EP | disclosed |
| EP-2480192-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2480193-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2015-08-19 | — | — | EP | disclosed |
| EP-2705879-A1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | Henkel AG&Co. KGAA (DE) | 2014-03-12 | — | — | EP | disclosed |
| EP-2413890-A2 | ANTIPERSPIRANT SPRAYS WITH ESTER OILS | Henkel AG & Co. KGaA (DE) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010112459-A2 | ANTIPERSPIRANT SPRAYS WITH ESTER OILS | HENKEL AG & CO. KGAA (DE) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200085966-A1 | GLUCOSE OXIDASE-NANOPARTICLE BIOCONJUGATES FOR CANCER TREATMENT AND USES THEREOF | G6PD, PPOX, DUOX1 | MAPT 1559/4885TSHR 1477/4885LMNA 4207/4885 |
| US-20190134239-A1 | PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | CD47, PAICS, MKI67 | MAPT 1630/4885TSHR 1676/4885LMNA 564/4885 |
| US-20190134240-A1 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | PAICS, CD47, BID | MAPT 2318/4885TSHR 302/4885LMNA 3438/4885 |
| US-11931423-B2 | Glucose oxidase-nanoparticle bioconjugates for cancer treatment | G6PD, PPOX, DUOX1 | MAPT 1453/4885TSHR 1513/4885LMNA 4224/4885 |
| US-11857648-B2 | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy | PAICS, CD47, BID | MAPT 2318/4885TSHR 302/4885LMNA 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.